StockNews.AI
SLQT
StockNews.AI
22 days

SelectQuote (SLQT) Faces Investor Lawsuit After DOJ Steps into Medicare Sales Probe – Hagens Berman

1. SelectQuote faces DOJ scrutiny over alleged deceptive sales practices. 2. A 19% drop in share price occurred due to DOJ’s intervention on May 1, 2025. 3. Class-action lawsuit filed for investors misled from Sept 2020 to May 2025. 4. Claims include misrepresentation of Medicare Advantage services and acceptance of kickbacks. 5. Shares have declined over 40% in six months due to legal and reputational concerns.

6m saved
Insight
Article

FAQ

Why Very Bearish?

The DOJ intervention and class-action lawsuits indicate serious legal troubles, risking financial stability. Historical cases of similar lawsuits have led to long-term stock declines.

How important is it?

The legal challenges faced by SelectQuote directly threaten its operational integrity and investor confidence, making this news highly impactful.

Why Long Term?

Ongoing investigations and potential further legal actions could prolong negative sentiment and stock performance.

Related Companies

HIGAFLCNOUNHCI
SAN FRANCISCO, Sept. 04, 2025 (GLOBE NEWSWIRE) -- SelectQuote Inc. (NYSE: SLQT), a digital insurance platform known for selling Medicare Advantage plans, is facing heightened legal scrutiny after the U.S. Department of Justice (DOJ) intervened in a whistleblower lawsuit alleging deceptive sales practices. The federal action triggered a sharp 19% drop in SelectQuote’s share price on May 1, 2025, and has now led to a securities class-action lawsuit filed on behalf of investors. The suit, Pahlkotter v. SelectQuote Inc. et al., covers investors who purchased SelectQuote stock between September 9, 2020, and May 1, 2025, and alleges that the company misled the market about its business model and regulatory exposure. Hagens Berman urges SelectQuote investors who suffered substantial losses to submit your losses now. Class Period: Sept. 9, 2020 – May 1, 2025Lead Plaintiff Deadline: Oct. 10, 2025Visit: www.hbsslaw.com/investor-fraud/slqt Contact the Firm Now: SLQT@hbsslaw.com   844-916-0895 Allegations of Kickbacks and Misrepresentation At the heart of the complaint are claims that SelectQuote misrepresented its Medicare Advantage sales practices. While the company publicly promoted its services as offering “unbiased advice” and “neutral plan comparisons,” the lawsuit asserts that SelectQuote: Steered customers toward plans from insurers offering the highest commissions.Accepted illegal kickbacks in exchange for preferential treatment.Violated federal statutes, including the False Claims Act The DOJ’s complaint alleges that from 2016 through at least 2021, SelectQuote received tens of millions of dollars in improper payments and discriminated against less profitable customers by directing them away from lower-margin plans. Market Fallout and Investor Impact The DOJ’s involvement sent shockwaves through the market, with SelectQuote’s stock plunging nearly 20% in a single day. Over the past six months, shares have declined more than 40%, reflecting investor concern over the company’s legal exposure and potential reputational damage. The class-action lawsuit argues that SelectQuote’s public statements failed to disclose material risks tied to its sales practices, leading investors to overvalue the company’s growth prospects and revenue integrity. Hagens Berman Investigates Alleged Revenue Manipulation Shareholder rights firm Hagens Berman is investigating whether SelectQuote’s revenue was artificially inflated through deceptive conduct. Reed Kathrein, a partner at the firm, commented: “The DOJ’s intervention transforms this from a routine business dispute into a serious federal matter. We’re examining whether SelectQuote’s so-called ‘unbiased’ model was merely a façade for a kickback-driven sales engine.” If you invested in SelectQuote and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses now » If you’d like more information and answers to frequently asked questions about the SelectQuote case and our investigation, read more » Whistleblowers: Persons with non-public information regarding SelectQuote should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email SLQT@hbsslaw.com. About Hagens BermanHagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.  Contact: Reed Kathrein, 844-916-0895

Related News